#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz

Medical News

léčebného konopí2

Extract of Medical Cannabis Now Available for Czech Patients. What Benefits Does It Bring?

17. 3. 2023 Source: Medical Cannabis

At the end of 2022, a new drug based on cannabis extract Naxiva Panaxol by Neuraxpharm was approved in the Czech Republic. It can be prescribed by specialists treating patients with chronic intractable pain. The treatment is covered by public health insurance.

leky na srdce

Relationship Between Mortality and Use of Statins or RAAS Inhibitors After Aortic Valve Replacement

The impact of prescribed medication after transcatheter aortic valve replacement (TAVR) has not been precisely assessed to date. A recently published retrospective analysis of clinical practice data…
16. 3. 2023 Source: Sartans in the Treatment of Hypertension
leky na astma

Efficacy and Safety of Dupilumab in the Treatment of Severe Asthma Insufficiently Controlled by Standard Therapy –⁠ Current Clinical Practice Data

If severe bronchial asthma with type 2 inflammation is insufficiently controlled by combined maintenance therapy, dupilumab –⁠ a recombinant monoclonal antibody inhibiting the signaling pathway of…
16. 3. 2023 Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation
léčebné konopí

Neuraxpharm Introduces a New Form of Medical Cannabis

Since November 2022, a new medication containing an active full-spectrum cannabis extract –⁠ Naxiva Panaxol from Neuraxpharm –⁠ has been available in the Czech Republic. The cannabis extract is offered…
16. 3. 2023 Source: Medical Cannabis
SUMMIT

Critical Conditions in Obstetrics 2022: What is Available in the Czech Republic for Managing Peripartum Life-Threatening Bleeding?

On December 10, 2022, a professional meeting entitled Critical Conditions in Obstetrics 2022 was held in the lecture hall of the new building of the National Museum in Prague. Prof. MUDr. Antonín…
14. 3. 2023 Source: Postpartum Hemorrhage
kyselina hyaluronová

Efficacy of Hyaluronic Acid Eye Drops in the Treatment of Dry Eye Syndrome –⁠ Results of a Meta-Analysis

Dry eye syndrome affects 5–30% of individuals over the age of 50. The beneficial effect of hyaluronic acid on the symptoms of this condition has been well described in both preclinical and clinical…
13. 3. 2023 Source: Ophthalmologic Diseases
prof. Lišková

Prof. Petra Lišková: Prevention of Dry Eye Syndrome is Difficult but Not Impossible

Dry eye syndrome is one of the most common ophthalmological problems, and its incidence is rising. Ophthalmologist Prof. MUDr. Petra Lišková, Ph.D., from the Clinic of Pediatrics and Hereditary…
13. 3. 2023 Source: Ophthalmologic Diseases
Par_choroba

Development and Benefits of Intestinal Gel LECIG for Patients with Parkinson's Disease

Patients with advanced Parkinson's disease, for whom the current regimen of orally and transdermally administered medications is insufficient for symptom relief, now have a new treatment option. It…
10. 3. 2023 Source: Parkinson's Disease
Par._choroba

Intestinal Gel LECIG in the Treatment of Advanced Parkinson's Disease in Real Practice

A recently published study presents the first experiences with an intestinal gel containing a triple combination of antiparkinsonian drugs and dosed via an infusion pump through percutaneous…
10. 3. 2023 Source: Parkinson's Disease
Kubeš_foto

Doc. Jiří Kubeš: The major benefit of proton therapy lies in protecting healthy tissues

Nearly 9,000 patients with oncological diseases have already undergone modern proton radiotherapy at the Proton Center in Prague. Which diagnoses are suitable for this treatment modality, what are…
7. 3. 2023 Source: Proton Radiotherapy
bacteria

Intestinal Infection of Multi-Resistant NDM-Producing K. pneumoniae in a Patient with NK/T Lymphoma –⁠ Case Study

The incidence of NDM-producing Klebsiella pneumoniae is increasing worldwide. NDM beta-lactamase is a significant cause of multidrug resistance in enterobacteria to various antibiotics, including…
3. 3. 2023 Source: Anti-Infectives
Pozvánka na ZEPOSIA STAND ALONE MEETING

Invitation to ZEPOSIA STAND ALONE MEETING

On behalf of Bristol Myers Squibb, we warmly invite you to the Zeposia Stand Alone Meeting, which will take place on March 22, 2023, at 5 PM at the EA Hotel Tereziánský dvůr in Hradec Králové.
2. 3. 2023 Source: Modulation of S1P in the Treatment of Autoimmune Diseases
syndrom karpálního tunelu

Carpal Tunnel Syndrome as a Warning Sign of Cardiomyopathy Caused by Transthyretin Amyloidosis

Recent study results suggest that transthyretin amyloidosis is a more common cause of heart failure than previously thought. Early diagnosis and subsequent therapy are key to improving patient…
2. 3. 2023 Source: Amyloidosis
infografika amyloidoza

INFOGRAPHIC: Diagnostic Algorithm for Cardiac Amyloidosis

What examinations are needed when cardiac amyloidosis is suspected? Which tests can distinguish transthyretin amyloidosis from systemic disease caused by immunoglobulin light chains? We bring you a…
27. 2. 2023 Source: Amyloidosis
AML

Current Position of Venetoclax in the Treatment of AML −⁠ Hope for a Better Prognosis?

The treatment of acute myeloid leukemia (AML) remained stagnant for a long time, with many new drugs emerging only in the past few years. One of the newest and most important is the Bcl-2…
27. 2. 2023 Source: Acute Myeloid Leukemia
1 … 32 33 34 35 36 … 111
Filter by speciality
Remove filters
Popular this week
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#